Amedisys (AMED) numbers raised at Jefferies. Shares of AMED now seen reaching $14, Jefferies said. Estimates also raised on improving admissions trends. Hold rating.
(INTC - Get Report)
target reduced at Sterne Agee. Shares of INTC now seen reaching $22, according to Sterne Agee. Inventory remains high, given lower PC demand. Neutral rating.
estimates, target raised at BMO. Shares of IVZ now seen reaching $28, according to BMO Capital. Estimates also increased, as the company is gaining market share.
numbers lowered at Jefferies. Shares of PCG now seen reaching $45, Jefferies said. Estimates also lowered on San Bruno regulatory overhang. Hold rating.
estimates cut at BMO through 2013, BMO Capital said. Company sold more debt to pay for new drill ships. Outperform rating and $65 price target.
estimates, target upped at Morgan Stanley. SNDK estimates were boosted through 2013, Morgan Stanley said. NAND market appears to be improving. Overweight rating and new $52 price target.
numbers increased at UBS. SNI estimates were raised through 2013, UBS said. Scatter market and ratings have recently improved. Neutral rating and new $61 price target.
target raised at Wunderlich to $54, according to Wunderlich. Turner should help lead subscription fee growth. Buy rating.
>To submit a news tip, email:
READERS ALSO LIKE:
and become a fan on